title: The Explorer study: the first double-blind RCT to assess the efficacy of TLC-NOSF on DFUs.
abstract: Urgo Medical recently announced the launch of the Explorer study, a large, Europe-wide, clinical study on the efficacy and tolerability of UrgoStart Contact, a lipidocolloid technology dressing impregnated with nano-oligosaccharide factor, in the treatment of diabetic foot ulceration. The number of patients, investigating centres and countries involved, as well as the length of treatment and patient follow-up, make this an ambitious, double-blind, randomised controlled trial.
authors.forename: D R
authors.initials: DR
authors.lastname: Shanahan
mesh_terms: D000328:Adult; D047070:Bandages, Hydrocolloid; D002266:Carboxymethylcellulose Sodium; D017719:Diabetic Foot / Q000628:therapy*; D005060:Europe; D006801:Humans; D015337:Multicenter Studies as Topic; D053758:Nanoparticles; D009844:Oligosaccharides; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
chemical_list: D009844:Oligosaccharides; D002266:Carboxymethylcellulose Sodium